Fagan Associates’s Teladoc Health TDOC Stock Holding History

Fagan Associates’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,892	Closed	-$3.8M	–	133
2021 Q1	$3.8M	Buy	20,892 +13,545	+184%	+$3.14M	0.89%	34
2020 Q4	$1.47M	Buy	7,347 +1,299	+21%	+$264K	0.37%	59
2020 Q3	$1.33M	Buy	6,048 +388	+7%	+$82.2K	0.38%	56
2020 Q2	$1.08M	Buy	+5,660	New	+$992K	0.34%	59

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fagan Associates's TDOC Position: Q2 2021 in Review

Fagan Associates sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 20,892 shares — an estimated $3.8M sold.

Fagan Associates first reported a position in TDOC in Q2 2020 and held it in 4 quarters. The position peaked at $3.8M in Q1 2021. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

Fagan Associates reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
Fagan Associates sold 20,892 Teladoc Health shares in Q2 2021, an estimated $3.8M.
Fagan Associates first reported a position in Teladoc Health in Q2 2020 and held it in 4 quarters.
Fagan Associates's Teladoc Health position peaked at $3.8M in Q1 2021.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Fagan Associates's 13F filing for Q2 2021, filed 6 Aug 2021.